N-Acetyl Semax.
9 Inquiries
2920938-90-3
Shanghai
100mg/bag
2026-04-10
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
N-Acetyl Semax. is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
N-Acetyl Semax
Other Name:Polypeptide Impurity 29 (N-Acetyl Semax Amidate);N-Acetyl Semax Amidat;AC-SEMAX
CAS No.:2920938-90-3
Molecular Formula:C39H54N10O10S
InChIKeys:QQOAKFVAEDCKGY-HPMAGDRPSA-N
Molecular Weight:854.97
Categories:
Characteristics-
Density:
1.364±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
Boiling Point:1422.9±65.0 °C(predicted)
PKA:4.43±0.10(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History9 Inquiries
Country Product Purchase Quantity Date Posted 
United States
N-Acetyl Semax Amidate
1 G Dec 31, 2025
United States
N-Acetyl Semax Amidate
5 G Aug 5, 2026 
North Macedonia
N-Acetyl Semax Amidate
1 KG Jul 17, 2026 
United Arab Emirates
N-Acetyl Semax Amidate
100 MG Mar 10, 2026 
India
N-Acetyl Semax Amidate
1000 MG Dec 8, 2025
India
NA Semax amidate
1 KG Dec 8, 2025
United States
N-Acetyl Semax Amidate
1 G Aug 8, 2026 
Serbia
n-acetyl semax
100 MG Apr 1, 2026
United States
N-acetyl semax amidate
10 PCS Sep 15, 2025 Post an enquiry for this product